Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure (Q44027030)

29 November 2017

Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure (English)

1 reference

29 November 2017

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

Takayuki Saito

1

1 reference

29 November 2017

Fu Hu

2

1 reference

29 November 2017

Lara Tayara

3

1 reference

29 November 2017

Linda Fahas

4

1 reference

29 November 2017

Hani Shennib

5

1 reference

29 November 2017

Adel Giaid

6

1 reference

29 November 2017

1 July 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

29 November 2017

1 reference

29 November 2017

283

1 reference

29 November 2017

H339-45

1 reference

29 November 2017

1

1 reference

Production of oxidative products of nitric oxide in infarcted human heart

29 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Nitric oxide attenuates cardiac myocyte contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Dexamethasone inhibits the expression of an inducible nitric oxide synthase in infarcted rabbit myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Nitric oxide and cardiac function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Nitric oxide synthases in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Myocardial contractile response to nitric oxide and cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Protective effects of cyclosporin-A in splanchnic artery occlusion shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

Myocardial ischemia/reperfusion injury in the inducible nitric oxide synthase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00596.2001

10.1152/AJPHEART.00596.2001

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference